Dorsal raphe projection inhibits the excitatory inputs on lateral habenula and alleviates depressive behaviors in rats
Dorsal raphe projection inhibits the excitatory inputs on lateral habenula and alleviates depressive behaviors in rats
复制标题
中缝背侧投射抑制外侧缰核的兴奋性输入并减轻大鼠的抑郁行为
DOI:
10.1007/s00429-018-1623-3
复制
发表时间:
2018
影响因子:
3.1
通讯作者:
Chen Jian Guo
中科院分区:
文献类型:
--
作者:
Zhang Hai;Li Kuan;Chen Hong Sheng;Gao Shuang Qi;Xia Zhi Xuan;Zhang Jie Ting;Wang Fang;Chen Jian Guo
Hypofunction of the serotonergic (5-HT) system has close relationship with the symptoms in major depressive disorders (MDD), however, the underlying neural circuitry mechanisms are not fully understood. Lateral habenula (LHb) plays a crucial role in aversive behaviors and is activated in conditions of depression. It has been reported that 5-HT inhibits the excitability of LHb neurons, leading to the hypothesis that decreased transmission of 5-HT would elevate the activity of LHb and therefore mediates depressive symptoms. Using retrograde tract tracing with cholera toxin subunit B, we find that dorsal raphe nucleus (DRN) sends primary 5-HT projection to the LHb. In vitro slice patch-clamp recording reveals that opto-stimulation of DRN inputs to the LHb suppresses the frequency of miniature excitatory postsynaptic current, while increases paired pulse ratio in LHb neurons, indicating 5-HT projection presynaptically suppresses the excitability of LHb neurons. In chronic unpredictable mild stress (CUMS) rat model of depression, optogenetic stimulation of DRN–LHb projection alleviates the depressive symptoms in CUMS models. Meanwhile, opto-inhibition of this circuit results in elevated c-fos expression in LHb and induces depression-like behaviors. This study demonstrates that the 5-HT projection from DRN to LHb suppresses the excitability of LHb neurons, and hypofunction of 5-HT transmission induces depressive behavior via the activation of LHb. Our results reveal the functional connectivity of DRN–LHb circuit and its antidepressant action, which may provide a novel target for the treatment of depression.